Although NGs are promising in terms of their application in the targeted therapies and in controlled delivery, they still have several limitations. Only a few NGs have been tested in clinical trials. There is a lack of large-scale investigations that deeply analyze the problem of NGs' behavior ...
Supplementation with Jlus66 reduced DSS-induced upregulation of cytokine levels such as TNF-伪, IL-1尾, and IL-6 (p<0.05). The NF-魏B pathway and MAPK pathway were inhibited, and the expression of TJ proteins (ZO-1, Occludin, and Claudin-3) was upregulated. 16S rRNA sequencing of ...